Yasuhiro Otomo

This inventor holds 7 USPTO granted patents and 3 EPO patents. Top assignees: Sysmex Corporation, Human Metabolome Technologies, Inc.. Active years: 2011-2021.

USPTO Granted Patents = 7

% Patents Active = 57.1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

Human Metabolome Technologies, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10900084 - Method for supporting diagnosis of risk of colorectal cancer recurrence, treatment of colorectal cancer, and administration of anticancer drug (2021-01-26),

2. 9898574 - Method for determining the presence of disease (2018-02-20),

3. 8945841 - Method of judging lymph node metastasis of stomach cancer (2015-02-03),

4. 8927221 - Diagnostic marker for kidney diseases and use thereof (2015-01-06),

5. 8465924 - Treatment solution for preparing sample solution for nucleic acid amplification reaction and method for detecting nucleic acid by using treatment solution (2013-06-18),

6. 8187809 - Method for judging lymph node metastasis of stomach cancer and kit used therefor (2012-05-29),

7. 8053193 - Method and apparatus for judging the presence or absence of cancer cell (2011-11-08),

Title: Yasuhiro Otomo: Innovator in Colorectal Cancer Diagnosis and Treatment

Introduction

Yasuhiro Otomo is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of medical diagnostics and treatment, particularly in colorectal cancer. With a total of 7 patents, his work has the potential to impact patient care and outcomes significantly.

Latest Patents

Otomo's latest patents include a method for supporting the diagnosis of the risk of colorectal cancer recurrence. This method involves measuring the expression levels of various genes in biological samples from patients. Additionally, he has developed a method for determining the presence of diseases by analyzing gene expression in samples from subjects suspected of having specific conditions. These innovations highlight his commitment to advancing medical technology and improving diagnostic accuracy.

Career Highlights

Throughout his career, Yasuhiro Otomo has worked with notable companies such as Sysmex Corporation and Human Metabolome Technologies, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in cancer diagnostics.

Collaborations

Some of his notable coworkers include Kazuki Nakabayashi and Hideki Takata. Their collaborative efforts have contributed to the development of innovative solutions in the medical field.

Conclusion

Yasuhiro Otomo's work in colorectal cancer diagnosis and treatment exemplifies the importance of innovation in healthcare. His patents and collaborations reflect a dedication to improving patient outcomes through advanced medical technologies.